{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:41:36Z","timestamp":1761766896497,"version":"3.37.3"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1124\/jpet.120.000337","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:25:13Z","timestamp":1615580713000},"page":"336-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition"],"prefix":"10.1016","volume":"377","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-3000","authenticated-orcid":false,"given":"Chad R.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Kangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Jutkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Winger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Coop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1124\/jpet.120.000337_bib1","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1590\/1516-4446-2013-1098","article-title":"Animal models as tools to study the pathophysiology of depression","volume":"35","author":"Abelaira","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib2","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00213-019-05278-0","article-title":"The protein kinase C\u03b2-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats","volume":"236","author":"Altshuler","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000337_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/c39920000817","article-title":"Synthesis, physicochemical and conformational properties of (3R, 4R)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1- azabicyclo[2.2.1]heptane, a novel M1 selective muscarinic partial agonist","volume":"11","author":"Baker","year":"1992","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1124\/jpet.120.000337_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006205-199211000-00018","article-title":"Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs","volume":"17","author":"Blair","year":"1992","journal-title":"Nurse Pract"},{"key":"10.1124\/jpet.120.000337_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000337_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.000337_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.31.060407.125618","article-title":"Neurocognitive mechanisms in depression: implications for treatment","volume":"32","author":"Clark","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.120.000337_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.120.000337_bib10","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/DDDT.S221437","article-title":"Ketamine and depression: a narrative review","volume":"13","author":"Corriger","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/jpet.120.000337_bib11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1039\/p19910001091","article-title":"A synthesis of 1-azabicyclo[2.2.1]heptane-3-carboxylic acid esters in enantiomerically pure form","volume":"5","author":"Cottrell","year":"1991","journal-title":"J Chem Soc Perkin Trans 1"},{"key":"10.1124\/jpet.120.000337_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vascn.2009.07.003","article-title":"Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat","volume":"60","author":"Delaunois","year":"2009","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.120.000337_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.174.4011.788","article-title":"The cholinergic synapse and the site of memory","volume":"174","author":"Deutsch","year":"1971","journal-title":"Science"},{"key":"10.1124\/jpet.120.000337_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/bs.apha.2020.04.002","article-title":"The antidepressant efficacy of the muscarinic antagonist scopolamine: past findings and future directions","volume":"89","author":"Drevets","year":"2020","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine\u2019s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s40265-016-0655-3","article-title":"Vortioxetine: a review in cognitive dysfunction in depression","volume":"76","author":"Frampton","year":"2016","journal-title":"Drugs"},{"key":"10.1124\/jpet.120.000337_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0024-3205(93)90306-N","article-title":"The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo","volume":"52","author":"Freedman","year":"1993","journal-title":"Life Sci"},{"key":"10.1124\/jpet.120.000337_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(92)90618-E","article-title":"L-687,306: a functionally selective and potent muscarinic M1 receptor agonist","volume":"215","author":"Freedman","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.npp.1301461","article-title":"Selective effects of cholinergic modulation on task performance during selective attention","volume":"33","author":"Furey","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.000337_bib24","series-title":"Muscarinic Receptors","first-page":"299","article-title":"Muscarinic receptor agonists and antagonists: effects on cardiovascular function","author":"Harvey","year":"2019"},{"key":"10.1124\/jpet.120.000337_bib25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1039\/p19930001421","article-title":"Enantiospecific synthesis of the (4R)-1-azabicyclo[2.2.1]heptane ring system","volume":"1","author":"Houghton","year":"1993","journal-title":"J Chem Perkin Trans"},{"key":"10.1124\/jpet.120.000337_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HRP.0000000000000230","article-title":"Gender differences in depression: biological, affective, cognitive and sociocultural factors","volume":"28","author":"Hyde","year":"2020","journal-title":"Harv Rev Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib27","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1242\/jeb.204.14.2439","article-title":"Cone-based vision of rats for ultraviolet and visible lights","volume":"204","author":"Jacobs","year":"2001","journal-title":"J Exp Biol"},{"key":"10.1124\/jpet.120.000337_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00179923","article-title":"Discriminative stimulus properties of muscarinic agonists","volume":"93","author":"Jung","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000337_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.103.061242","article-title":"Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats","volume":"309","author":"Jutkiewicz","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000337_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.drugalcdep.2012.12.021","article-title":"Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats","volume":"131","author":"Jutkiewicz","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.000337_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008877-200311000-00003","article-title":"Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats","volume":"14","author":"Jutkiewicz","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/FBP.0000000000000356","article-title":"Touchscreen technology in the study of cognition-related behavior","volume":"28","author":"Kangas","year":"2017","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.115.228189","article-title":"Comparisons of \u03949-tetrahydrocannabinol and anandamide on a battery of cognition-related behavior in nonhuman primates","volume":"357","author":"Kangas","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000337_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1901\/jeab.2010.94-69","article-title":"Titrating-delay matching-to-sample in the pigeon","volume":"94","author":"Kangas","year":"2010","journal-title":"J Exp Anal Behav"},{"key":"10.1124\/jpet.120.000337_bib35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","article-title":"Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers","volume":"163","author":"Kessler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.120.000337_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2015.03.016","article-title":"Forced swim test: what about females?","volume":"99","author":"Kokras","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.120.000337_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.120.000337_bib39","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/acschemneuro.8b00615","article-title":"Dark classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens","volume":"10","author":"Lakstygal","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.120.000337_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1101\/lm.043133.116","article-title":"Muscarinic acetylcholine receptors act in synergy to facilitate learning and memory","volume":"23","author":"Leaderbrand","year":"2016","journal-title":"Learn Mem"},{"key":"10.1124\/jpet.120.000337_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib42","doi-asserted-by":"crossref","first-page":"a005710","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/jpet.120.000337_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/17470214808416738","article-title":"The breakdown of vigilance during prolonged visual search","volume":"1","author":"Mackworth","year":"1948","journal-title":"Quat J Exper Psych"},{"year":"2011","series-title":"Guidelines for the care and use of laboratory animals","key":"10.1124\/jpet.120.000337_bib44"},{"key":"10.1124\/jpet.120.000337_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2014.07.046","article-title":"Faster, better, stronger: towards new antidepressant therapeutic strategies","volume":"753","author":"O\u2019Leary","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000337_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1192\/bjp.182.3.214","article-title":"Neurocognitive impairment in drug-free patients with major depressive disorder","volume":"182","author":"Porter","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib48","doi-asserted-by":"crossref","first-page":"5480391","DOI":"10.1155\/2016\/5480391","article-title":"AlaiShehni S, and Kouti, L (2016) Cognitive function before and during treatment with selective serotonin reuptake inhibitors in patients with depression or obsessive-compulsive disorder","volume":"2016","author":"Sayyah","year":"2016","journal-title":"Psychiatry J"},{"key":"10.1124\/jpet.120.000337_bib49","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/jm00107a032","article-title":"Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands","volume":"34","author":"Showell","year":"1991","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000337_bib50","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/jm00172a003","article-title":"Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors","volume":"33","author":"Street","year":"1990","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000337_bib51","doi-asserted-by":"crossref","first-page":"112047","DOI":"10.1016\/j.bbr.2019.112047","article-title":"Psychomotor retardation in depression: a critical measure of the forced swim test","volume":"372","author":"Unal","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.120.000337_bib52","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/14737175.2015.1071192","article-title":"Five potential therapeutic agents as antidepressants: a brief review and future directions","volume":"15","author":"Wang","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1124\/jpet.120.000337_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130050590","article-title":"The effects of dopaminergic agents on reaction time in rhesus monkeys","volume":"137","author":"Weed","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000337_bib54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0278-5846(90)90073-P","article-title":"Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test","volume":"14","author":"West","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.120.000337_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/FBP.0000000000000537","article-title":"Comparison of the muscarinic antagonist effects of scopolamine and L-687,306","volume":"31","author":"Winger","year":"2020","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib56","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0022-3565(25)39176-7","article-title":"Comparison of in vitro actions with behavioral effects of antimuscarinic agents","volume":"242","author":"Witkin","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000337_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.114.216804","article-title":"M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine","volume":"351","author":"Witkin","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000337_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.apha.2019.03.002","article-title":"Rapid-acting antidepressants","volume":"86","author":"Witkin","year":"2019","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.apha.2020.03.003","article-title":"Involvement of muscarinic receptor mechanisms in antidepressant drug action","volume":"89","author":"Witkin","year":"2020","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.120.000337_bib60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0091-3057(93)90004-D","article-title":"Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats","volume":"44","author":"Yamamoto","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.120.000337_bib61","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J Vis Exp"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:01:04Z","timestamp":1739973664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022356524270257"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000337","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}